SCHEMBL2592404

SCHEMBL2592404

C(=Nc1ccc(-c2ccccc2)cc1)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 5/20 0.60
CA1 P00915 4/20 0.60
PTGS2 P35354 2/20 0.56
CA9 Q16790 2/20 0.56
CA12 O43570 1/20 0.56
L3MBTL1 Q9Y468 5/20 0.50
ALDH1A1 P00352 5/20 0.50
KDM4E B2RXH2 3/20 0.50
GLA P06280 1/20 0.50
S100B P04271 1/20 0.49
LMNA P02545 3/20 0.48
PTGS1 P23219 1/20 0.47
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
MAPT P10636 4/20 0.45
THRB P10828 3/20 0.45
MAPK1 P28482 2/20 0.45
TP53 P04637 1/20 0.45
ALOX15 P16050 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5442784 1.00 CA2 (0.60) CA2CA1PTGS2CA9CA12
SCHEMBL2451394 0.98 CA2 (0.62) CA2CA1PTGS2CA9CA12
SCHEMBL2451391 0.98 CA2 (0.62) CA2CA1PTGS2CA9CA12
Water SCHEMBL11627560 0.95 CA2 (0.60) CA2CA1PTGS2CA9CA12
SCHEMBL10688872 0.91 ALDH1A1 (0.60) CA2CA1PTGS2CA9CA12
SCHEMBL10688876 0.91 ALDH1A1 (0.60) CA2CA1PTGS2CA9CA12
SCHEMBL28981268 0.91 ALDH1A1 (0.60) CA2CA1PTGS2CA9CA12
SCHEMBL3417678 0.91 CA2 (0.69) CA2CA1PTGS2CA9CA12
SCHEMBL3417682 0.91 CA2 (0.69) CA2CA1PTGS2CA9CA12
SCHEMBL27412905 0.88 CA1 (0.54) CA2CA1PTGS2CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070261806-A1 Treatment of Pulp Stocks Using Oxidative Enzymes to Reduce Pitch Deposition ENZYMATIC DEINKING TECHNOLOGIES, LLC 2007-11-15 US claimed
EP-0707637-B1 ENHANCEMENT OF LACCASE REACTIONS NOVOZYMES AS (DK) 2005-11-02 EP claimed
EP-1137391-B1 METHOD FOR TREATING HAIR NOVOZYMES AS (DK) 2004-11-03 EP claimed
CN-1112475-C Enzymatic discharge printing of dyed textiles NOVO ZEMITZ NORTH AMERICA INC (US) 2003-06-25 CN claimed
US-6572843-B1 Combining permanent dyeing and straightening; applying to reduced hair an oxidizing enzyme (Laccase), a mediator, and a chemical oxidizing agent that produces hydrogen peroxide NOVOZYMES, A/S (DK) 2003-06-03 US claimed
EP-0679183-B1 ENHANCEMENT OF ENZYME REACTIONS NOVOZYMES AS (DK) 2003-04-16 EP claimed
CN-1334718-A Hair treatment method NOVOZYMES AS (DK) 2002-02-06 CN claimed
US-20020007524-A1 Contacting fibers in a dry state with an oxidoreductase and a dye precursor; reduced hair damage NOVOZYMES A/S (DK) 2002-01-24 US claimed
EP-1137391-A1 METHOD FOR TREATING HAIR Novozymes A/S (DK) 2001-10-04 EP claimed
EP-1076494-A1 RE-FORMATION OF KERATINOUS FIBRE CROSS LINKS Novozymes A/S (DK) 2001-02-21 EP claimed
WO-2000032158-A1 METHOD FOR TREATING HAIR NOVOZYMES A/S (DK) 2000-06-08 WO claimed
CN-1252846-A Enzymatic discharge printing of dyed textiles NOVO NORDISK BIOCHEM INC (US) 2000-05-10 CN claimed
WO-1999058013-A1 RE-FORMATION OF KERATINOUS FIBRE CROSS LINKS NOVO NORDISK A/S (DK) 1999-11-18 WO claimed
US-5951714-A Enzymatic discharge printing of dyed textiles NOVO NORDISK BIOCHEM NORTH AMERICA, INC. (US) 1999-09-14 US claimed
US-5899212-A CLEAVAGE OF DISULFIDE BONDS, OXIDOREDUCTASE NOVO NORDISK A/S (DK) 1999-05-04 US claimed
US-5885304-A AROMATIC COMPOUNDS CONTAINING AT LEAST TWO RINGS, AT LEAST ONE SUBSTITUTED WITH NITROGEN OXYGEN, OR SULFUR NOVO NORDISK A/S (DK) 1999-03-23 US claimed
EP-0707637-A1 ENHANCEMENT OF LACCASE REACTIONS NOVO NORDISK A/S (DK) 1996-04-24 EP claimed
EP-0679183-A1 ENHANCEMENT OF ENZYME REACTIONS NOVO NORDISK A/S (DK) 1995-11-02 EP claimed
WO-1995001426-A1 ENHANCEMENT OF LACCASE REACTIONS NOVO NORDISK A/S (DK) 1995-01-12 WO claimed
WO-1994012621-A1 ENHANCEMENT OF ENZYME REACTIONS NOVO NORDISK (DK) 1994-06-09 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020007524-A1 Contacting fibers in a dry state with an oxidoreductase and a dye precursor; reduced hair damage KRT18, CYB5R3, ADH7 CA2 1133/4885CA1 1106/4885PTGS2 1047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.